WHO pauses approval of Quebec’s Medicago COVID-19 vaccine due to tobacco industry ties
A World Health Organization official said a COVID-19 vaccine developed by a Quebec pharmaceutical firm will “very likely” not be approved for emergency use due to the company’s links to the tobacco industry.
“The WHO has now paused the application for pre-qualification of Quebec City-based Medicago’s new Covifenz shot, citing the company’s ties to cigarette maker Philip Morris International.”
THE BLOCKING OF NON-MRNA VAXX OPTIONS CONTINUES — SEE YESTERDAYS NOVAVAX ARTICLE AND TODAY IT’S MEDICAGO’S TURN!